CXCL9 and breast carcinoma: Previous studies have demonstrated that high levels of CXCL9 mRNA are associated with prolonged survival in patients with breast cancer (Li et al., 2020), particularly the TNBC subtype (Razis et al., 2020; Lv et al., 2021).